Secondary prevention of coronary heart disease
a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Keywords:
Heart diseases, Coronary disease, Secondary prevention, Risk factors, Cohort studiesAbstract
BACKGROUND: Coronary heart disease (CHD) remains a major cause of mortality worldwide and in Brazil. Use of standard medications after CHD has been proven to avoid new events and reduce early mortality. OBJECTIVES: This study aimed to analyze secondary prevention of CHD and its association with the base-line characteristics of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). DESIGN AND SETTING: Cross-sectional analysis on ELSA-Brasil data. METHODS: Secondary prevention of CHD recommended in standard guidelines (antiplatelet plus be-ta-blocker plus lipid-lowering drug, with or without angiotensin-converting enzyme inhibitors, ACEI, or angiotensin receptor blockers, ARB) was evaluated in relation to sociodemographic data and the time since the coronary event. The chi-square test, one-way analysis of variance (ANOVA) and Mann-Whitney test were performed, as necessary. RESULTS: Among 15,094 participants, 2.7% reported a previous diagnosis of CHD. Use of recommended drugs for secondary prevention was reported by almost 35% of the participants. Medication use for sec-ondary prevention was generally more frequent among high-income participants than among low-income participants. Use of ARB and ACEI was different between participants who had private health insurance and those who only used the public healthcare system. Men were more likely to use medication than women. The frequency with which participants used the recommended drugs was similar in all time periods after CHD, but use of only one drug increased progressively across time periods. CONCLUSION: The use of medication for secondary prevention of CHD was lower than what is recom-mended in standardized guidelines, especially among women and lower-income participants
Downloads
References
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-210. PMID: 28919116; doi: 10.1016/S0140-6736(17)32152-9.
Santos IS, Goulart AC, Brandão RM, et al. One-year mortality after an acute coronary event and its clinical predictors: The ERICO study. Arq Bras Cardiol. 2015;105(1):53-64. PMID: 25993485; doi: 10.5935/abc.20150044.
Ergatoudes C, Thunstrom E, Rosengren A, et al. Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome. BMC Cardiovasc Disord. 2016;16(1):226. PMID: 27855640; doi: 10.1186/s12872-016-0400-6.
Piegas LS, Timerman A, Nicolau JC, et al. III Diretriz sobre tratamento do infarto agudo do miocárdio [III Guidelines on the treatment of myocardial acute infarction]. Arq Bras Cardiol. 2004;83 (suppl 4):1-86. PMID: 15580315; doi: 10.1590/S0066-782X2004002200001.
Lima RC, Kubrusly LF, Nery ACS, et al. Sociedade Brasileira de Cardiologia. Diretrizes da Cirúrgia de Revascularização Miocárdica [Guidelines for myocardial revascularization surgery]. Arq Bras Cardiol. 2004;82(suppl 5:1-20. PMID: 15122460.
Smith SC Jr, Allen J, Blair SN, et al; AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363-72. PMID: 16702489; doi: 10.1161/CIRCULATIONAHA.106.174516.
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127(4):e362-425. PMID: 23247304; doi: 10.1161/CIR.0b013e3182742cf6.
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–651. PMID: 22064601; doi: 10.1161/CIR.0b013e31823ba622.
Koopman C, Vaartjes I, Heintjes EM, et al. Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010. Eur Heart J. 2013;34(41):3198-205. PMID: 24046432; doi: 10.1093/eurheartj/eht368.
Manteuffel M, Williams S, Chen W, et al. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt). 2014;23(2):112-9. PMID: 24206025; doi: 10.1089/jwh.2012.3972.
Du L, Cheng Z, Zhang Y, Li Y, Mei D. The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis. Eur J Prev Cardiol. 2017;24(9):962–70. PMID: 28436725; doi: 10.1177/2047487317695628.
Reuter H, Markhof A, Scholz S, et al. Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention. Eur J Prev Cardiol. 2015;22(7):890– 8. PMID: 24938277; doi: 10.1177/2047487314540385.
Aquino EM, Barreto SM, Benseñor IM, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and Design. Am J Epidemiol. 2012;175(4):315–24. PMID: 22234482; doi: 10.1093/aje/kwr294.
Schmidt MI, Duncan BB, Mill JG, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2015;44(1):68-75. PMID: 24585730; DOI: 10.1093/ije/dyu027.
Bensenor IM, Griep RH, Pinto KA, et al. Routines of organization of clinical tests and interviews in the ELSA-Brasil investigation center. Rev Saude Publica. 2013;47 Suppl 2:37-47. PMID: 24346719.
Chor D, Alves MG, Giatti L, et al. Questionário do ELSA-Brasil: desafios na elaboração de instrumento multidimensional [Questionnaire development in ELSA-Brasil: challenges of a multidimensional instrument]. Rev Saúde Pública. 2013;47 Suppl 2:27-36. PMID: 24346718.
Aquino EM, Vasconcellos-Silva PR, Coeli CM, et al. Aspectos éticos em estudos longitudinais: o caso do ELSA-Brasil [Ethical issues in longitudinal studies: the case of ELSA-Brasil]. Rev Saúde Pública. 2013;47 Suppl 2:19-26. PMID: 24346717.
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human Kinetics Publishers; 1988.
Fedeli LG, Vidigal PG, Leite CM, et al. Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil. Rev Saude Publica. 2013 Jun;47 Suppl 2:63-71. PMID: 24346722.
Lewis G, Pelosi AJ, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med. 1992;22(2):465-86. PMID: 1615114.
Nunes MA, de Mello Alves MG, Chor D, Schmidt MI, Duncan BB. Cross-cultural adaptation of CIS-R (Clinical Interview Schedule-Revised Version) for the Portuguese in Longitudinal Study Of Adult Health (ELSA) [Adaptação transcultural do CIS-R (Clinical Interview Schedule - Revised Version) para o português no Estudo Longitudinal de Saúde do Adulto (ELSA)]. Revista HCPA. 2012;31(4):487–490.
Previdelli AN, Andrade SC, Pires MM, et al. A revised version of the Healthy Eating Index for the Brazilian population. Rev Saude Publica. 2011;45(4):794-8. PMID: 21655703.
Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95. PMID: 12900694; doi: 10.1249/01. MSS.0000078924.61453.FB.
Matsudo S, Araújo T, Matsudo V, et al. International physical activity questionnaire (IPAQ): study of validity and reliability in Brazil [Questionário internacional de atividade física (IPAQ): Estudo de validade e reprodutibilidade no Brasil]. Rev bras ativ fís saúde. 2001;6(2):5-18. doi: https://doi.org/10.12820/rbafs.v.6n2p5-18.
Treff C, Benseñor IM, Lotufo PA. Leisure-time and commuting physical activity and high blood pressure: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Hum Hypertens. 2017;31(4):278-83. PMID: 27734826; doi: 10.1038/jhh.2016.75.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. PMID: 3945130.
Dal Pizzol TS, Trevisol DJ, Heineck I, et al. Adherence to essential medicines in cities from three Brazilian states. Cad Saúde Pública. 2010;26(4):827-36. PMID: 20512222.
Jackevicius CA, Cox JL, Carreon D, et al. Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ. 2009;181(1-2):E19-28. PMID: 19581604; doi: 10.1503/ cmaj.081913.
Sheppard RJ, Schiffrin EL. Inhibition of the renin–angiotensin system for lowering coronary artery disease risk. Curr Opin Pharmacol. 2013;13(2):274-9. PMID: 23523606; doi: 10.1016/j. coph.2013.03.001.
Chor D, Pinho Ribeiro AL, Sá Carvalho M, et al. Prevalence, Awareness, Treatment and Influence of Socioeconomic Variables on Control of High Blood Pressure: Results of the ELSA-Brasil Study. PLoS One. 2015;10(6):e0127382. PMID: 26102079; doi: 10.1371/journal. pone.0127382.
Lotufo PA, Santos RD, Figueiredo RM, et al. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Clin Lipidol. 2016;10(3):568-76. PMID: 27206944; doi: 10.1016/j. jacl.2015.12.029.
Kweon S, Sohn MK, Jeong JO, et al. Quality of Life and Awareness of Cardiac Rehabilitation Program in People With Cardiovascular Diseases. Ann Rehabil Med. 2017;41(2):248-56. PMID: 28503458; doi: 10.5535/ arm.2017.41.2.248.
Ghisi GL, dos Santos RZ, Aranha EE, et al. Perceptions of barriers to cardiac rehabilitation use in Brazil. Vasc Health Risk Manag. 2013;9:485-91.PMID: 24039433; doi: 10.2147/VHRM.S48213.
Borghi-Silva A, Mendes RG, Trimer R, Cipriano G Jr. Current trends in reducing cardiovascular disease risk factors from around the world: focus on cardiac rehabilitation in Brazil. Prog Cardiovasc Dis. 2014;56(5):536-42. PMID: 24607019; DOI: 10.1016/j.pcad.2013.09.008.
Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57(10):1096-103. PMID: 15528061; doi: 10.1016/j.jclinepi.2004.04.005.
